MYRIAD GENETICS INC (MYGN) Stock Profile — Insider Trades & Financials

Revenue$209.8M

Net Income-$7.9M

EPS$-3.95

Gross Margin70.0%

Market Cap$443.7M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Sam Raha

CEO & Executive Director

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

Employees: 2,600
Headquarters: SALT LAKE CITY, UT, United States
Website

⚡

Core Efficiency

ROE?

-2.15%

ROA?

-1.12%

D/E Ratio?

0.92

Op. Margin?

-2.72%

📊

Profitability Ratios

Net Margin?

-3.77%

Loading company sections...

MYRIAD GENETICS INC

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness